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Cellularreprogramming was recently‘‘crowned’’with theaward of
the Nobel Prize to two of its groundbreaking researchers, Sir John
Gurdon and Shinya Yamanaka. The recent link between reprog-
ramming and stem cells makes this appear almost a new ﬁeld of
research, but its historical roots have actually spanned more than
a century. Here, the Nobel Prize in Physiology or Medicine 2012
is placed in its historical context.
Introduction
Research is a gradual process offering ﬂashes of brilliance
and occasionally much more, as reward for tenacity. The
physicist/historian/philosopher Thomas Kuhn described
scientiﬁc advance as a series of interrelated bodies of work
wherein discovery builds upon discovery (Kuhn, 1970).
Kuhn articulated the vexation that arises when attempting
to assign priority among scientists for a given break-
through; one example considered whether it was Priestley
or Lavoisier who legitimately ‘‘discovered’’ oxygen (you
be the judge). The incremental nature of investigation
also proves difﬁcult when seeking to pin down the exact
timingthatanindividualdiscoverywasmade:theso-called
‘‘Eureka moment.’’ Here, Kuhn discussed Roentgen’s work
leading to the description of X-rays and the inability
to deﬁne the moment of discovery along the trajectory
of that research. Stem cell research is no less a product
of cumulative, integrated effort between and within
laboratories. Truly, experiencing the collaborative nature
of research is among the greatest pleasures in a scientiﬁc
career.
Thatsaid, there arebrightlinesinthehistoryofanyﬁeld,
moments in which a particular observation drew away the
curtain and set researchers on an exciting new course.
In the 112 years since its inception, the Nobel Prize in
Physiology or Medicine has recognized the contributions
of luminaries within their respective disciplines. Pavlov,
Cajal,Fleming,Luria,McClintock,Krebs,andmanyothers,
some ofwhom will bediscussed below, were joined in 2012
bySirJohnB.GurdonandShinyaYamanakainrecognition
oftheir groundbreakingwork showing that ‘‘.mature cells
can be reprogrammed to become pluripotent’’ (2012
Nobel Prize winners in medicine, http://www.nobelprize.
org/nobel_prizes/medicine/laureates/2012/)( Figure 1).
Gurdon and Yamanaka’s work mark a new beginning in
the study of development, cellular lineage determination,
and our understanding of epigenesis. This review will
brieﬂy summarize milestones in the ﬁeld’s history leading
to the 2012 Nobel and offer a reading of tea leaves
regarding things to come (for an abbreviated timeline, see
Table S1 available online).
Before the Beginning
As Kuhn might well have observed, the question ‘‘When
did stem cell research begin’’? is interesting to ponder but
difﬁcult to answer. A response depends in part upon
deﬁning what one considers as stem cell research. What
is clear is that the notion of replacing, repairing, or even
regrowing damaged body parts is rooted in antiquity.
Although Aeschylus often receives the credit in his ﬁfth
century work Prometheus Bound, it was actually in the
eighthcenturyB.C.workTheogonythattheGreekpoetHes-
iod ﬁrst described the legend of Prometheus who gave ﬁre
to humans and was punished by Zeus by being chained
to a rock so that a large eagle could swoop in and devour
his liver. The cruelty of Prometheus’ sentence was com-
pounded by the fact that his liver would fully regenerate
by the next day so that the punishment could be repeated.
What makes this ancient story incredible is that the liver
actually has a tremendous capacity for postresection repair
in which over 70% may be surgically removed only to
regenerate (for review, see Duncan et al., 2009).
In the third century A.D., the twin brothers Damian and
Cosmas, later Patron Saints of Physicians, would achieve
fame(andmartyrdom) byworkingas healersfreeofcharge.
Among their purported deeds was the successful grafting
of an entire leg from one person onto another. To the
modern reader, this procedure went so far as to include a
form of cellular lineage tracing given that the transplanted
leg bore dark skin, whereas the recipient’s ﬂesh tone was
white. Regardless of the veracity of stories such as these,
the point remains that for a very long time, humankind
has understood the concept of replacing diseased or
damaged tissue with healthy counterparts. It is remarkable
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have actually taken place.
The years prior to the dawn of the 19
th century brought
additional advances; no doubt considered unrelated at
the time but when looking back with the perfect vision of
hindsight, nevertheless deﬁne a continuum of discovery
leading to the 2012 Nobels. Among these are the ﬁrst
publications during the Renaissance describing human
teratomas, benign tumors bearing representative tissues
from all three somatic germ layers: ectoderm, mesoderm,
and endoderm (e.g., Birch and Tyson, 1683; Scultetus,
1658; Yonge, 1706).
Today, we understand teratomas to derive from germ cell
precursors (Teilum, 1965), arising primarily within the
gonad of both sexes but also occurring throughout the
mediastinum given the migratory route of primordial
germ cells prior to their arrival in the genital ridge during
embryogenesis (Witschi, 1948). Given their three germ
layer composition, the tumor-initiating cell of a teratoma
is termed ‘‘pluripotent’’ or capable of forming all tissue
types found in the adult soma (for review, see Lensch
et al., 2007). Flashing forward to the mid-1950s, it was
Leroy Stevens working at the Jackson Laboratory who
noted that the low frequency of testicular teratoma present
in the inbred 129 mouse strain had a genetic basis that
might be capable of ampliﬁcation to the point of study at
the cellular level (Stevens and Little, 1954). Stevens’ work
would link the descriptive studies of mid-17
th century
medical curiosities to the clonal isolation of the ﬁrst
pluripotent stem cells in mice: the embryonal carcinoma
(EC) cell (Kleinsmith and Pierce, 1964)( Figure 2), which
has served as an invaluable resource capable of culture
in vitro (Martin and Evans, 1974) and permitting inves-
tigators to probe many mysteries of early development
(for review, see Andrews, 2002). More on pluripotency
momentarily.
The Renaissance also marked the ﬁrst medically related
transfer of cells into a human patient, the unfortunate
Mr. Arthur Coga, in the form of blood transfusions using
a rather surprising donor: a young sheep (Lower and
King, 1667). The invention of this procedure also launched
a furious priority of discovery battle between French and
English physicians that played out within the pages of
the Philosophical Transactions for several issues, despite
the fact that animal-into-human blood transfusion proved
to be a disappointing clinical practice.
Moving ahead less than 100 years, experiments began to
be much better deﬁned. Some regard Abraham Trembley
as the legitimate forbearer of regeneration research (see
Parson, 2004). A winner of the Copley Medal of the Royal
Society of London in the year 1743 in recognition of his
investigations of freshwater hydrozoans, Trembley would
publish his master work in 1744 that detailed the hydra’s
regenerative capacity following experimental dissections
of tremendous variety (Trembley, 1744). The work set the
stage for the ﬂedgling ﬁeld of experimental zoology in gen-
eral and the empirical study of regeneration in particular.
Down the Rabbit Hole
1797 was a banner year in developmental biology. Cruik-
shank published his description of developing staged em-
bryos in vivo within the rabbit fallopian tubes and uterus
extending to the early somite stages (Cruikshank, 1797).
The work within the Cruikshank paper was performed
nearly 20 years prior to publication and stands as a mile-
stone in the ﬁeld of embryology. The study was facilitated
in part by mentoring and funding from his senior
colleague, the renowned scientist and surgeon John
Hunter. The study would not have been possible but
for improvements in optics, and earlier works detailing
the features of the mammalian reproductive system.
Cruikshank’s paper relies upon and cites prior studies,
some in Latin, by Leuwenhoek, Harvey, and De Graaf,
among others. It also highlights the importance of using
appropriate model organisms in research when seeking to
better understand the complexities of mammalian embry-
onic development.
It was the research of yet another rabbit fancier, Walter
Heape, that profoundly altered scientiﬁc views on gesta-
tion and development and in a manner that runs counter
to his present scientiﬁc obscurity. Working at Cambridge
in the 1890s, Heape performed the ﬁrst live-embryo trans-
fer experiment when he mated purebred Angora rabbits
Figure 1. Winners of the 2012 Nobel Prize in Physiology or
Medicine: Sir John B. Gurdon and Shinya Yamanaka
The photo was taken at the ISSCR-Roddenberry International
Symposium on Cellular Reprogramming only 10 days after the
announcement of the laureates for 2012. Photo credit: Chris
Goodfellow/Gladstone Institutes.
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32 hr later at the four-cell stage, and placed them into
the distal end of the fallopian tube of a purebred, Belgian
rabbit doe mated for the ﬁrst time only 3 hr earlier to a
purebred Belgian buck (a breed with short, brown fur)
(Heape, 1890).
The thinking of the day suggested that the uterine
environment of the Belgian might have an inductive effect
on the transferred embryos, perhaps contributing charac-
teristics in a horizontal manner, conforming to the views
of Lamarck among others, to the gestating Angoras pro-
vided they grew in the foster uterus at all. Heape’s paper
of barely two pages likely caused a stir at the Royal Society
when it reported the live birth of four Belgian offspring
and two undeniable Angoras, the exact number he had
transferred. Heape painstakingly built upon these studies,
becoming an aﬁcionado of artiﬁcial insemination tech-
niques as he focused his later efforts on estrus. His work
in some ways sounded the starter’s pistol for later research
into entities such as embryonic chimeras and the deriva-
tion and culture of mammalian embryonic cell lines
in vitro.
Heape was also a contemporary of August Weismann
who would not only deliver the coup de gra ˆce to the
Lamarckian concept of the transmissibility of acquired
characteristics but who would also throw down the pro-
verbial gauntlet within the ﬁeld to experimentally deﬁne
the genetic basis of developmental speciﬁcation within a
growing organism.
Nuclear Equivalence—The Sine Qua Non of Cellular
Reprogramming
The University of Freiburg’s August Weismann was an in-
tellectual giant and champion of the germ-plasm theory,
Figure 2. Relationships between Pluripo-
tent Stem Cells and Embryos: 50 Years of
History in Mice
Pluripotent stem cells can arise from NT-
derived (cloned) blastocysts, fertilized
embryos or teratocarcinomas, spontaneous
tumors of the testis, or tumors induced by
transferring early embryos to extrauterine
sites. ESCs and EC cells will form chimeras if
introduced into preimplantation embryos
that are transferred to a pseudopregnant
female mother. ESCs will be chimeric in the
germline and give rise to sperm and eggs,
but EC cells do not chimerize the germline.
A less stringent test for pluripotency of
ESCs than germline contribution is the
ability to form benign teratomas after
injection in immune-deﬁcient mice. This
test is also used to demonstrate pluripo-
tency in human ESCs. A more stringent
test is ‘‘tetraploid complementation,’’ where
the entire postnatal animal is ESC derived.
Teratocarcinomas are thought to derive
spontaneously from deregulated primordial
germ cells (PGCs) that give rise to the
gametes.Pluripotentstemcelllinescanalso
be derived as embryonic germ (EG) cells
directly from PGCs. mEC, mouse embryonal
carcinoma; mESC, mouse embryonic stem
cell; miPSC, mouse induced pluripotent
stem cell; mEG, mouse embryonic germ.
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cells in the germline, not the soma (Weismann, 1893).
His 1889 landmark publication falsiﬁed Lamarck’s view
that acquired characteristics, such as somatic mutilations,
would be inherited by the offspring of the afﬂicted animal
(Weismann, 1889). To prove this, Weismann performed a
simple experiment: he cut off the tails of seven female
and ﬁve male white mice and then mated them to one
another. When their offspring were born, he measured
their tail length, recorded it, and then snipped their tails
as well. These F1s were raised to adulthood, bred, and their
offspring were treated inthesamemanner.Theprocesswas
repeated for ﬁve generations and a total of 901 mice.
Despite his efforts, Weismann found that tail length did
not decline, and whereas he would not state that it never
could if there were an inﬁnite number of iterations, he
conﬁdently concluded that over the span of a few genera-
tions, acquired mutilations to the soma had no measurable
heritability. Whatever shaped subsequent generations, it
came from the gametes alone.
Turning his attention to development, he then asked a
related question: How does the cellular diversity present
within a complicated multicellular organism arise from
a single starting cell? Others had long wondered the same
thing, and among the more prevalent theories was that
ofpreformationthatdescribedan‘‘unfolding’’ofstructures
present a priori: many small but incomplete individuals in
the gametes that grew larger during development. Such a
notionwasintensionwithtenetsofthegerm-plasmtheory
given that determinants must be present within the
dividing zygote that would be allocated only to the germ-
line and not the somatic cells. Weismann proposed that
as the early embryo cleaved, the genes were divided among
daughter cells, with the possible exception of the germline
that would by necessity contain an entire complement
(termed the idioplasm), and that this series of ‘‘qualitative
divisions’’ was the basis of cellular lineage speciﬁcation.
The mechanisms by which this segregation would take
place were difﬁcult to envision, and noted biologists,
including Theodor Boveri, were quick to point this out
along with additional criticisms. However, such a theory
had also been proposed by the experimentalist Wilhelm
Roux, who set out to test the hypothesis.
Roux reasoned that if qualitative division accounted for
different developmental trajectories within an embryo,
then early removal of individual cells should prohibit
formation of an entire organism. He tested this by pricking
one cell of a two-celled frog embryo using a heated needle.
Roux found that this procedure compromised the develop-
mental capacity of entire embryos in support of the
qualitative division theory (Roux, 1888). Work by others,
including Thomas Hunt Morgan (Nobel Prize, 1933)
(Morgan, 1895), arrived at similar conclusions though,
importantly, would also suggest that experimental arti-
facts, such as whether or not one left the damaged cell in
contact with the remaining intact cell, urged additional
experiments. Among those taking up the question but
employing alternative approaches were Oscar Hertwig,
Hermann Endres, Amedeo Herlitzka, and Hans Driesch
(see Spemann, 1938).
Driesch used a different model organism, the sea urchin,
and a new technique to disaggregate the blastomeres at the
two-cell stage. Employing the method of calcium-depleted
sea water devised by the embryologist Curt Herbst, the
sea urchin blastomeres were easily separated from one
another following gentle agitation and developed into
two complete organisms (Driesch, 1891). Not only was
this perhaps the ﬁrst cloning experiment, it also disagreed
with Weismann and Roux.
Yet, another approach and model organism would
provide the most convincing evidence that Weismann’s
theory was likely incorrect. Hans Spemann (Nobel Prize,
1935), also of the University of Freiburg, and his colleague
Hilde Mangold were dedicated experimentalists interested
in a wide variety of developmental phenomenon ranging
from eye formation to early embryonic organizers and
patterning. The work of Roux et al. was of great interest
to Spemann, and he entered the fray using fertilized eggs
of the common newt, Triton taeniatus. He also turned to
an experimental approach developed by Oscar Hertwig,
namely the use of thin, ﬂexible ﬁbers (ranging from silk
threads to the hair from a baby’s head in practice) to
constrict developing embryos into halves. Using this
method and building upon earlier attempts by Endres
and Herlitzka, Spemann was the ﬁrst to clone a developing
vertebrate (via ‘‘forced-twinning,’’ if you will) when he
published results demonstrating the complete develop-
ment of newts originating from the same egg (Spemann,
1928). Spemann’s experiment drove the nails into the
cofﬁn of Weismann and Roux’s position. The work sug-
gested that the complement of genes in the various cells
of developing organisms was the same, a concept termed
‘‘nuclear equivalence.’’ Although Spemann’s experiment
fails to explain exactly how cellular lineage speciﬁcation
does occur, it rather importantly shows how it does not.
The qualitative division theory was out. Thanks to Spe-
mann’s work, we now know that developmental changes
arise by epigenesis: the selective restriction of gene ex-
pression from among the entire genomic complement
present within the many cell and tissue types in the
body. Later investigators including the University of
Edinburgh’s Conrad Hal Waddington would eloquently
theorize about the effect of epigenetic restriction on
cellular identity (Waddington, 1957). Deﬁning the molec-
ular details of lineage speciﬁcation remains at the cutting
edge of current science.
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ment and Induction (Spemann, 1938), Spemann would
issue marching orders to the next wave of researchers
seeking to further test the validity of nuclear equivalence
when he wrote (on page 211):
Decisive information about this question may perhaps
be afforded by an experiment which appears, at ﬁrst
sight, to be somewhat fantastical . Probably the same
effect could be attained if one could isolate the nuclei
of the morula and introduce one of them into an egg
or an egg fragment without an egg nucleus . This
experiment might possibly show that even nuclei of
differentiated cells can initiate normal development in
the egg protoplasm.
Why didn’t Spemann attempt the experiment himself?
The answer is that whereas he had ideas for how to isolate
nuclei by grinding cells between glass slides, he did not
know how to transfer a free nucleus into another cell.
The idea would have to wait 14 years to be taken up in
earnest by two investigators from Philadelphia.
When Fantasy Becomes Reality
The story goes that Robert Briggs had not heard of
Spemann’s ‘‘fantastical’’ idea. However, a senior colleague
of his, the Drosophila geneticist Jack Schultz (who himself
had been a student of Morgan’s), brought the experiment
to his attention. Briggs invited a young fellow, the embry-
ologist Thomas J. King, to join him, and together with
technical assistance from Marie DiBerardino, they put
Spemann’s proposal to the test. Like Weismann’s deter-
mination that the conclusions made from his tail clipping
experimentscould notbeextrapolated beyondthe number
of generations he had actually tested, Spemann likewise
knew that his own data regarding nuclear equivalence
extended only as far as the developmental stage of the
embryos he had used. Was it possible that at some later
developmentalstagenuclearequivalencemightbeinvalid?
This was the hypothesis tested in Briggs and King’s nuclear
transfer (NT) studies.
To develop the NT method, the model organism of
choice for the majority of the work was the frog Rana
pipiens, though among the many clever components in
the paper was the intentional construction of R. pipiens/
Rana catesbeiana hybrid nuclei as a validation of the
transfer procedure (Briggs and King, 1952). The recipient
egg is activated via needle prick, which causes the cyto-
plasm to rotate and enables the aspiration of the pronu-
cleus with a glass needle. The jelly coating of the egg is
then removed, and attention turns to obtaining donor
nuclei. Animal pole cells within the donor blastula are
individually dissected away from the mass so that single
cells may be drawn into a glass pipette with an inner
diameter less than that of the donor cell. Drawing the
donor cell into the narrow pipette causes it to rupture,
at which point it is injected into the recipient-enucleated
egg.
The investigators obtained nuclei from the blastula stage
of development when the cleaving structure contains
thousands of cells. Their data indicate that of 194 eggs
injected, 104 cleaved (52.8%), and 63 of these (60.6%)
went on to reform complete blastulae. What is more, of
50 complete, ‘‘reconstituted’’ blastulae that were allowed
to develop beyond the stage from which the nuclei had
been obtained, roughly three-quarters completed normal
gastrulation, and half of these went on successfully beyond
theneurulastage,thepointatwhichtheneuraltubeforms.
Thus, not only was nuclear equivalence maintained at a
stage of organismal development containing thousands
of cells, but the nuclei also remained fully capable of
guiding integrated development onward in the majority
of cases.
Caveats of the work, also discussed by the authors,
include the transfer of a small amount of blastula cell
cytoplasm along with the donor nucleus, which may
have inﬂuenced the experimental outcome, perhaps by
diluting the much greater volume of egg cytoplasm. Also,
and as similarly observed by other experimentalists
mentionedabove,theinterpretationsoftheworkextended
only so far as the age of the donor nuclei employed. The
use of blastula nuclei, and not those from later stages of
development, was intentional in the Briggs and King study
because they wished to determine the efﬁciency of the
technique using nuclei from an undifferentiated cell type
bearingahighprobabilityforsupportingfulldevelopment.
Their goal in 1952 was not to see how far they could
push the system but whether it would work at all. Still,
the study was a tour de force, and the establishment of
the NT technique would permit others to ask even bolder
questions regarding nuclear equivalence. Among the
earliest investigators attempting NT was a group at the
University of Oxford that used it in another species of
frog, Xenopus laevis (Fischberg et al., 1958). That team
included a young graduate student named John Gurdon
(Nobel Prize, 2012).
NT Comes of Age
Gurdon produced a cavalcade of high-impact work using
NT to investigate the developmental potency of differenti-
ating nuclei. Among these studies was the demonstration
that despite a low frequency of success, highly specialized
and differentiated cells from tissues such as the intestinal
tract maintained the ability to complement the lost poten-
tial of the enucleated egg (Gurdon, 1962). Such NT-derived
frogs, proven to be entirely donor nucleus derived via
cellular lineage tracing, could even developmentally
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transplantation’’ scheme was employed in which NT em-
bryos derived from intestinal cell donors were permitted
to develop to the blastulae stage and then used in a second
round of NT. In this subsequent stage, NT blastula-derived
nuclei were obtained for another round of NT from which
embryos were allowed to develop to adulthood and tested
for reproductive capacity (Gurdon and Uehlinger, 1966).
The correlation between declining nuclear potency and
increasing developmental maturity of donor cells was
another key insight (Gurdon, 1960). Despite the inefﬁ-
ciency of NT, the technique could be used to generate
functioning organisms from additional types of differenti-
ated cells as nuclear donors. Tissues as developmentally
mature as keratinocytes (Gurdon et al., 1975) and lympho-
cytes (Wabl et al., 1975) would nevertheless prove capable
of complementing enucleated frog eggs in rare cases.
Gurdon’s pioneering work paved the way for a wealth of
studies demonstrating that even mammals like sheep
(Campbell et al., 1996; Wilmut et al., 1997) and mice
(Wakayama et al., 1998, 2000) could be cloned. In fact, it
is important to point out that in examples such as Dolly
the sheep (the ﬁrst mature mammal to be directly cloned
in a single round of NT; Wilmut et al., 1997), and the
ﬁrst cloned mice (Wakayama et al., 1998), the transferred
nuclei were restored or reprogrammed to totipotency, i.e.,
the ability to form not only all of the cells of the adult
organism(asisthecase forpluripotency)butalsotheentire
cadre of extraembryonic tissues including the trophecto-
derm of the placenta.
Later studies would sharpen the nuclear equivalency
point by demonstrating that cells as fully differentiated as
murine B and T lymphocytes were capable of producing
monoclonal mice following a multistep procedure wherein
NT was performed to generate blastocysts from which em-
bryonic stem cells (ESCs) were derived that in turn were
used to chimerize diploid or tetraploid embryos (Hoched-
linger and Jaenisch, 2002)( Figure 2). In the case of tetra-
ploid complementation, murine embryos fused at the
two-cell stage (yielding a 4n embryo, which contains four
haploid genome equivalents) will support the growth of
the trophectoderm, but not the inner cell mass of the
embryo from which the embryonic mouse arises; transfer-
ring diploid (2n) pluripotent stem cells into 4n blastocysts
complements their inability to complete development
(Nagy et al., 1990). In the case of the tetraploid studies,
the lymphocyte origin of the resulting animals was veriﬁed
by immunoglobulin gene rearrangement signatures in all
tissues. Even the nuclei of sensory neurons retain the rare
ability to produce mice via a similar, multistep approach
and tetraploid complementation, where once again, the
origins of the cells in the resulting mice were veriﬁed via
cellular lineage tracing (Eggan et al., 2004).
A good experiment generates questions as well as an-
swers. Although decades of work provide overwhelming
support to the validity of nuclear equivalence, they fail to
explain why NT works at all. What is the mechanism by
which the egg cytoplasm ‘‘instructs’’ the incoming nucleus
to reset its epigenetic state to a much earlier form? What
factors are involved? What are the central genetic regula-
tors of pluripotency or even totipotency? Although many
havepondered these samequestions, it would beinvestiga-
tors working at Kyoto University in the mid-2000s who
offered some rather provocative responses. Before we get
to that, it is worth dipping back brieﬂy into the history
books once again.
The First Isolation of Native ESCs
Going back to the mouse experiments on teratomas
mentioned earlier and the isolation of pluripotent EC cells,
it was known that despite being obtained from abnormal
tissue growths (see Lensch and Ince, 2007), EC could
nevertheless contribute to the soma once transferred
into normal embryos (Brinster, 1974). It was a natural
step to then consider whether or not pluripotent cells
werecapableofisolationfromnormaltissues,i.e.,theearly,
preimplantation embryo. The answer to this question
was a resounding ‘‘yes,’’ and in 1981, Martin Evans (Nobel
Prize, 2007) and Matthew Kaufman from the University of
Cambridge (Evans and Kaufman, 1981) and their colleague
GailMartinfromtheUniversityofCalifornia-SanFrancisco
(Martin, 1981) independently published papers describing
the generation, extended culture, and differentiation ca-
pacity of lines of ESCs.
For Evans’ ESC isolations from the 129 mouse strain, a
state of diapause or arrest of embryonic development (for
review, Lopes et al., 2004) was imposed via ovariectomy
2.5 days after mating. This caused embryos hatched from
thezona pellucida to increasetheircellnumbers somewhat
without implantation prior to recovery less than 1 week
later. Explanted blastocysts were then cocultured on a
feeder layer of immortalized murine ﬁbroblast STO cells
in serum-containing media, yielding lines of cells resem-
bling EC cells but with a normal karyotype. The investiga-
tors also demonstrated their developmental capacity via
in vitro differentiation as cystic embryoid bodies, teratoma
formation in vivo, and, though not detailed in this ﬁrst
publication, mouse chimeras.
Investigators have long been able to also obtain and
study the gametes and developing concepti of many other
species including humans (e.g., Jordan, 1918). Extensive
study of ovulation, fertilization, and embryo transfer (for
review, see Biggers, 2012; Johnson, 2010) would prove
capable of clinical application when Patrick Steptoe and
Robert Edward (Nobel Prize, 2010) assisted the formerly
childless Brown family to bring Louise into the world; the
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(IVF) (Steptoe and Edwards, 1978).
In 1994, Arif Bongso, an IVF specialist at the University
Hospital of Singapore, managed to obtain stem cell-like
colonies from surplus IVF embryos (Bongso et al., 1994)
but had little experience in culture of pluripotent cells
or access to their markers so was unable to establish lines
and prove their identity. However, in 1998, James A.
Thomson and colleagues from the University of Wiscon-
sin demonstrated that stem cell colonies could likewise
be obtained by culturing human embryos, which were
generated by IVF for implantation but then donated to
research (Thomson et al., 1998). Thomson’s group
managed to establish these colonies as cell lines. The
culture conditions used were similar to those employed
for their murine counterparts. A total of 14 inner cell
masses were obtained, and ﬁve distinct lines of human
ESCs arising from ﬁve different embryos were derived.
Each had a normal karyotype and proved capable of tera-
toma formation in immunodeﬁcient murine hosts. Both
murine and human ESCs express a variety of markers
similar to proteins found in EC cells as well as normal cells
present in the early embryo, including TRA-1-60, various
stage-speciﬁc embryonic antigens (SSEAs), and alkaline
phosphatase. ESCs also express telomerase and maintain
telomere length provided they are cultured in conditions
supporting the maintenance of pluripotency, which for
murine ESCs, includes culture medium containing leuke-
mia-inhibitory factor or LIF (Smith et al., 1988; Williams
et al., 1988).
Beyond the value of their contribution to the growing
lexicon of species from which ESCs might be derived, the
generation of human ESCs permitted study of the earliest
stages of human development in an empirical, hypothe-
sis-driven manner. Never before had it been possible to
study human tissue genesis, from the very ﬁrst stages of
uncommitted precursor cells through the elaboration of
differentiated cell types, as it happened in vitro. Further-
more, if combined with NT in a platform where the donor
nuclei were obtained from patient biopsies bearing genetic
disease, then one might additionally be able to probe the
impact of disease-causing genetic lesions on development
or even use the technology to deﬁne how to regenerate
‘‘matched’’ tissue for direct replacement as a cellular ther-
apy. As such, it is impossible to overstate the excitement,
potential impact, and value of human ESCs to the study
of human development, disease, and decay.
Following years of study, human NT was ﬁnally success-
ful provided the egg pronucleus was left in place; lines of
human NT-derived ES cells were derived albeit containing
triploid genomes (Noggle et al., 2011). However, while
this review was in press, human cellular reprogramming
studies took a leap forward when the laboratory of
Shoukhrat Mitalipov at Oregon Health & Science Univer-
sity published the highly efﬁcient derivation of multiple
lines of diploid hESC via NT, a process that was successful
(in part) due to the use of 1.25 mM caffeine to protect
oocytes from premature activation during spindle removal
(Tachibanaetal.,2013).Whatifitwerepossibletogenerate
disease- and patient-speciﬁc lines of human pluripotent
stem cells in a manner that did not rely on NT?
Cellular Reprogramming Changes the Game
Awealth of fascinating research was presented by scientists
from around the world at the 2006 meeting of the Interna-
tional Society for Stem Cell Research (ISSCR) in Toronto,
Ontario. Among the hundreds of posters and oral presenta-
tions delivered that year, the work of two investigators
from Kyoto University, Kazutoshi Takahashi and Shinya
Yamanaka (Nobel Prize, 2012), would not only fundamen-
tally alter the ﬁeld for years to come but with a degree of
rapidity unparalleled in modern science. Simply put, their
methodological approach to generate lines of ‘‘induced
pluripotent stem’’ or iPS cells was a saltatory breakthrough
of massive proportions that took the world of cell and
developmental biology by storm.
Publishing their full manuscript later that year, the
researchers demonstrated that a combination of four
retrovirally delivered factors, Oct4, Klf4, Sox2, and cMyc,
was capable of reprogramming murine adult and embry-
onic ﬁbroblasts to pluripotency (Takahashi and Yamanaka,
2006). Theirs was not the ﬁrst time that scientists had
demonstrated that nuclear equivalence permits ‘‘lineage
reassignment’’ by forced gene expression.
Working in the 1980s at the Fred Hutchinson Cancer
Research Center, Harold ‘‘Hal’’ Weintraub and colleagues
had successfully converted mouse ﬁbroblasts to muscle-
forming myoblasts via the enforced expression of a master
muscle transcription factor they had identiﬁed: MyoD
(Davis et al., 1987; Lassar et al., 1986; Tapscott et al.,
1988). The fulcrum around which reprogramming capa-
bility appears to revolve is the correct identiﬁcation of
proximal transcriptional regulators within a given lineage,
those capable of imposing a larger transcriptional proﬁle
speciﬁc to the intended tissue. The team from Kyoto
theorized that similarly acting transactivators likely existed
in pluripotent cells that given the proper context and
culture conditions, might prove capable of reprogramming
somatic cells to earlier stages of development. These in-
sights were gleaned from the aforementioned NT studies
as well as the use of cell fusion to study the ‘‘contingencies
of phenotype’’ in hybrid cells (Miller and Ruddle, 1976).
For several decades prior to the turn of the 21
st century,
researchers investigated the capacity of various cell types
to functionally inﬂuence or reprogram one another
following cell fusion (for review, see Graf, 2011). Although
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fusions between mouse teratocarcinoma-derived EC cells
and mature cell types such as ﬁbroblasts were inconclusive,
perhaps due to the speciﬁc EC lines used (e.g., Finch and
Ephrussi, 1967; Jami et al., 1973), other studies would
clearly demonstrate that the resulting hybrids were plurip-
otent (e.g., Miller and Ruddle, 1976; Andrews and Goodfel-
low, 1980). Despite abnormal ploidy, cell fusion hybrids
were capable of forming multilineage teratomas, a measure
of potency arising from the EC component, while simulta-
neously (and unambiguously) demonstrating continued
expression of genes from the fusion partner such as glucose
phosphate isomerase (Miller and Ruddle, 1976).
Later work showed that mouse ESCs were likewise
capable of imposing pluripotency onto hybrids generated
using a diverse array of somatic cell fusion partners
including Tcells (Tada et al., 2001), splenocytes (Matveeva
et al., 1998), bone marrow (Terada et al., 2002), and neural
progenitors (Ying et al., 2002). Human ESC-ﬁbroblast
fusion products are also pluripotent (Cowan et al., 2005).
What is more, despite the fact that all components from
each parent cell are present in the resulting hybrid, fusion
experiments following density gradient centrifugation
to obtain either ESC karyoplasts or cytoplasts revealed
that it is not the cytoplasm but rather the nucleus that
contains whatever factors are responsible for ‘‘reactivating’’
embryonic gene expression in the somatic partner (Do and
Scho ¨ler, 2004). Identifying these factors would permit
virtually any type of cell to be reprogrammed to
pluripotency.
The approach used by Takahashi and Yamanaka was
ingenious and involved compiling a set of 24 ‘‘candidate
factors’’: genes that were known to be highly associated
with pluripotency via prior studies in knockout mice, ES,
EC, and germ cells. All 24 factors were delivered to
ﬁbroblasts in a selection-based system in which the gene
Fbx15 drove a cassette conferring resistance to the anti-
biotic neomycin. The choice of the Fbx15 gene was impor-
tant as though it is expressed in ESCs and the early embryo
it is not expressed in ﬁbroblasts and thus, only reprog-
rammed cells would be drug resistant. Additionally,
Fbx15 knockout mice are viable, and thus, gene targeting
to introduce the neo-cassette was unlikely to impair
pluripotency while at the same time ensuring that reprog-
ramming-induced expression of Fbx15 would produce an
efﬁcient system with a low false-positive rate. The 24-factor
approach produced a certain threshold of colony forma-
tion that permitted the investigators to initiate a subtrac-
tion assay. One by one, single members of the set of 24
were removed to evaluate the remaining 23 in order to
identify which genes were indispensable for colony
growth. This resulted in the ﬁnal set of four ‘‘Yamanaka
factors.’’
The ﬁrst iPS cells met many of the functional standards
of mouse ESCs. They contained hypomethylated pro-
moters relative to the parent ﬁbroblasts for pluripotency-
associated genes including Nanog and Fbx15, grew in
colonies in vitro that were morphologically similar to
mouse ESCs, expressed SSEA-1 and alkaline-phosphatase,
had a normal karyotype, clustered with mouse ESCs and
away from ﬁbroblasts in gene expression microarray anal-
ysis, demonstrated expression of tissue-speciﬁc markers
such as smooth muscle actin and b-III tubulin when
differentiated in vitro, formed teratomas when injected
into murine hosts, and chimerized recipient embryos as
far as E13.5.
However, there were important measures of performance
that the ﬁrst iPS cells failed to meet including that there
were no live-born chimeric mice, and no studies were
capableofdemonstratingdeﬁnitivegermlinecontribution,
even among midgestation embryos. The reprogramming
frequency was also very low, hovering somewhere around
one colony per 6,000 starting ﬁbroblasts. By the following
year, investigators would reﬁne the approach by driving
drug-resistance/selection from other pluripotency-associ-
ated genes, a change that permitted live-born chimeras
with germline contributions (Maherali et al., 2007; Okita
et al., 2007; Wernig et al., 2007). Importantly, the basic
four-factor approach remained otherwise unaltered, sug-
gesting that the process likely produced a distribution of
cell types reprogrammed to different degrees and capable
of isolation or enrichment using alternative techniques
such as Fbx15 or Nanog-driven drug selection.
The application of cellular reprogramming to human
cells followed quite rapidly, also taking place at the con-
clusion of the year 2007 (Park et al., 2008b, which was
published online December 23, 2007; Takahashi et al.,
2007; Yu et al., 2007). Interestingly, the human iPS cells
from the Thomson lab were generated using a somewhat
different combination of factors, namely OCT4, SOX2,
NANOG, and LIN28 (Yu et al., 2007). LIN28 is a protein
demonstrated to be a central player in the maintenance
of pluripotency via the modulation of the let7 family of
microRNAs, which in turn regulate a variety of cellular
oncogenes (Viswanathan et al., 2008). Apparently, there
are many roads leading to pluripotency. Additionally,
whereas the cocktail of four genes appears at ﬁrst glance
to be a fairly simple recipe for imposing such a profound
developmental change onto cells, it is worth pointing out
that OCT4 and SOX2 each impact hundreds of other genes
in an extensive regulatory network (Boyer et al., 2005; Kim
et al., 2008; Loh et al., 2006).
Considering the goal of being able to generate lines of
human pluripotent stem cells that are matched to speciﬁc
patients, either to study genetic disease or as a possible
resource for regenerative therapy, iPS cells have a great
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cells included a sizeable compendium representing a wide
variety of complex, inherited, multifactorial, and single-
gene human conditions including Parkinson disease, type
I diabetes, Gaucher disease, Down syndrome, and others
(Park et al., 2008a) along with those derived from a patient
with ALS (Dimos et al., 2008).
The reﬁnement of iPS cell methods and applications has
been nothing short of inspired. Given that these subjects
have been extensively reviewed elsewhere, we will not
focus upon them here but will provide an overview of
the most immediate applications (Figure 3). Observing
that between Yamanaka’s ﬁrst announcement of his revo-
lutionary reprogramming methodology in Toronto and
his naming as a Nobel Laureate in Physiology or Medicine,
along with Sir John Gurdon, a short 6 years later, stands as
a testament to the robustness of his approach, its rapid and
wide-ranging acceptance within the ﬁeld, and the vast
array of exciting opportunities it presents to basic science
and biomedicine.
Looking Ahead
Many authors have and will provide conjecture regarding
the future of this ﬁeld. Among the more provocative twists
and turns of late are the papers indicating that cellular
reprogramming need not necessarily transit through a
pluripotent cell intermediate. Rather ‘‘direct reprogram-
ming’’ from and to a variety of mature or progenitor cell
types is possible via forced expression of sets of lineage-
associated genes. Examples include converting ﬁbroblasts
to neurons in mouse cells via the genes Brn2, Myt1l, and
Ascl1 (Vierbuchen et al., 2010) and in human cells using
a slightly different mix of BRN2 and MYT1L plus the
miR-124 microRNA (Ambasudhan et al., 2011). Again,
the outward simplicity of a handful of genes capable of
reprogramming cells hides the deeper truth of extensive
chromatinrearrangementsthattakeplacewhencellsadopt
a new identity.
Beyond experiments such as these, it is interesting to
wonder what the ‘‘outer limits’’ of cellular reprogramming
might be. Can any type of cell be converted to any other
type of cell? Given the correct genetic inducements
along with culture conditions capable of fostering cellular
intermediates during the transition, perhaps the answer is
‘‘yes.’’ That said, single cells do exist that present a rather
high bar for reprogramming including those with nondi-
ploid genetic content like red blood cells (which have no
nucleus at all) and megakaryocytes, which may contain
up to 128 or more haploid equivalents because their
genome endoreduplicates without cytokinesis during their
maturation toward platelet production.
Taking this question one step further, and in a more pro-
vocative vein, we observe that the mammalian zygote is a
single cell with a diploid genome. Might it be possible to
one day reprogram adult somatic cells to totipotency? In
other words, given the appropriate technology, might
every cell in the body acquire the developmental potential
of a fertilized egg? Given that cellular reprogramming is
based upon changing the gene expression of one cell type
to that of another, the answer would have to be ‘‘no.’’
Why? It is because of the curious state of gene expression
in the zygote. It has none.
The earliest cellular cleavages and stages of postfertiliza-
tion development are directed by the action of proteins
and mRNAs stored in the egg during oogenesis—a process
involving meiosis and occurring in a completely maternal
Figure 3. Derivation and Use of Human
Pluripotent Stem Cells
Human ES cells (hESCs) and iPS cells
(hiPSCs) have immediate applications in
modeling disease, drug discovery, and
safety pharmacology. Genetic or other
correction provides the appropriate control
cells for these studies. hESCs can be
targeted genetically to create disease
models and introduce different mutations
on an isogenic background. Alternatively,
disease-speciﬁc hESCs can be derived
from embryos that are rejected after pre-
implantation genetic diagnosis (PGD).
Longer-term applications are thought to
be in cell transplantation therapy. The
prototype human pluripotent stem cells
are EC stem cells (hECs) derived from
spontaneous teratocarcinomas. As in mice, pluripotent stem cells can also be derived from primordial germ cells in humans as human
embryonic germ cells (hEGCs), but these have usually not become stable lines (data not shown).
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2007; Tadros and Lipshitz, 2009). In humans, zygotic
gene expression appears to be activated somewhere near
to or after the eight-cell stage. In mice, it is even earlier at
the two-cell stage, but in the single-cell zygote, the genome
is silent.Fascinating recent work inmiceshowsthat atleast
four preimplantation pluripotent cells are required for
developmental progression in utero, though half embryos
are capable of being stimulated to duplicate the requisite
number of cells via modulation of ﬁbroblast growth factor
(FGF) and Wnt signaling such that forced monozygotic
twins may even be produced (rather as Spemann) (Morris
et al., 2012). However, though the authors managed to
enhance the potency of half embryos, their work did not
impose zygotic identity onto single cells. Thus, we end by
suggesting that cellular reprogramming to totipotency is
not possible. The gauntlet has been thrown down.
Final Word
The growing interest in stem cells among the scientiﬁc
community and patient groups led to the formation of
the ISSCR by Leonard I. Zon and a few enthusiastic sup-
porters just over 10 years ago. This fully ﬂedged society
now welcomes almost 4,000 delegates to its annual
meeting with thousands more following online from their
home labs. Its current president is Shinya Yamanaka. The
Society anticipates an exponential growth of the ﬁeld in
the coming decade and is now ready for its own journal,
Stem Cell Reports, which launched at the ISSCR’s annual
meeting in 2013. It is only ﬁtting that the inaugural issue
of the journal should include an article that reﬂects upon
the history of the ﬁeld, celebrates some of its heroes, and
looks forward in eager anticipation of future work that
will improve the quality of life for those with tissue dam-
age, degeneration, or other forms of disease for which
stem cell research promises relief.
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